Year: 2019
Type: article
Abstract: Human herpesvirus 6B (HHV-6B) establishes lifelong latent infection in most individuals after the primary infection. Encephalitis is the most severe complication caused by both the primary infection and the reactivation of HHV-6B and is the cause of considerable mortality in patients, without any established treatments to date. The humanization of the murine neutralizing antibodies described in this research provided a feasible way to reduce the inherent immunogenicity of the antibodies without changing their neutralizing activities. These newly designed chimeric antibodies against HHV-6B have the potential to be candidates for antivirals for future use.
Source: Journal of Virology
DOI: 10.1128/jvi.02270-18
Authors: Bochao Wang, Mitsuhiro Nishimura, Yuji Maekawa, Toshiya Kotari, Toshiomi Okuno, Yasuko Mori
Institutions: Kobe University, Hyogo Medical University
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W2921489620
